Literature DB >> 16950816

Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation.

Angela Pyle, Robert W Taylor, Steve E Durham, Marcus Deschauer, Andrew M Schaefer, David C Samuels, Patrick F Chinnery.   

Abstract

BACKGROUND: The 3243A-->G MTTL1 mutation is the most common heteroplasmic mitochondrial DNA (mtDNA) mutation associated with disease. Previous studies have shown that the percentage of mutated mtDNA decreases in blood as patients get older, but the mechanisms behind this remain unclear. OBJECTIVES AND
METHOD: To understand the dynamics of the process and the underlying mechanisms, an accurate fluorescent assay was established for 3243A-->G heteroplasmy and the amount of mtDNA in blood with real-time polymerase chain reaction was determined. The amount of mutated and wild-type mtDNA was measured at two time points in 11 subjects.
RESULTS: The percentage of mutated mtDNA decreases exponentially during life, and peripheral blood leucocytes in patients harbouring 3243A-->G are profoundly depleted of mtDNA.
CONCLUSIONS: A similar decrease in mtDNA has been seen in other mitochondrial disorders, and in 3243A-->G cell lines in culture, indicating that depletion of mtDNA may be a common secondary phenomenon in several mitochondrial diseases. Depletion of mtDNA is not always due to mutation of a nuclear gene involved in mtDNA maintenance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16950816      PMCID: PMC2597915          DOI: 10.1136/jmg.2006.043109

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  Noninvasive diagnosis of the 3243A > G mitochondrial DNA mutation using urinary epithelial cells.

Authors:  Martina T McDonnell; Andrew M Schaefer; Emma L Blakely; Robert McFarland; Patrick F Chinnery; Douglass M Turnbull; Robert W Taylor
Journal:  Eur J Hum Genet       Date:  2004-09       Impact factor: 4.246

2.  Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome.

Authors:  E Ciafaloni; E Ricci; S Servidei; S Shanske; G Silvestri; G Manfredi; E A Schon; S DiMauro
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

3.  Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease.

Authors:  E A Shoubridge; G Karpati; K E Hastings
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

4.  Mitochondrial DNA and RNA processing in MELAS.

Authors:  P Kaufmann; Y Koga; S Shanske; M Hirano; S DiMauro; M P King; E A Schon
Journal:  Ann Neurol       Date:  1996-08       Impact factor: 10.422

5.  Leber's hereditary optic neuropathy: biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype.

Authors:  V Carelli; A Ghelli; M Ratta; E Bacchilega; S Sangiorgi; R Mancini; V Leuzzi; P Cortelli; P Montagna; E Lugaresi; M Degli Esposti
Journal:  Neurology       Date:  1997-06       Impact factor: 9.910

Review 6.  Hematopoietic stem cells.

Authors:  P Quesenberry; L Levitt
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

7.  Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes.

Authors:  P F Chinnery; N Howell; R N Lightowlers; D M Turnbull
Journal:  Brain       Date:  1997-10       Impact factor: 13.501

8.  Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content.

Authors:  H Zhang; D A Cooney; A Sreenath; Q Zhan; R Agbaria; E E Stowe; A J Fornace; D G Johns
Journal:  Mol Pharmacol       Date:  1994-12       Impact factor: 4.436

9.  Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leucocyte DNA upon aging.

Authors:  L M 't Hart; J J Jansen; H H Lemkes; P de Knijff; J A Maassen
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

10.  MELAS: clinical features, biochemistry, and molecular genetics.

Authors:  E Ciafaloni; E Ricci; S Shanske; C T Moraes; G Silvestri; M Hirano; S Simonetti; C Angelini; M A Donati; C Garcia
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

View more
  25 in total

1.  Normal levels of wild-type mitochondrial DNA maintain cytochrome c oxidase activity for two pathogenic mitochondrial DNA mutations but not for m.3243A-->G.

Authors:  Steve E Durham; David C Samuels; Lynsey M Cree; Patrick F Chinnery
Journal:  Am J Hum Genet       Date:  2007-05-23       Impact factor: 11.025

2.  Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model.

Authors:  Riikka H Hämäläinen; Tuula Manninen; Hanna Koivumäki; Mikhail Kislin; Timo Otonkoski; Anu Suomalainen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

3.  Fall in circulating mononuclear cell mitochondrial DNA content in human sepsis.

Authors:  Angela Pyle; David J Burn; Charlotte Gordon; Catherine Swan; Patrick F Chinnery; Simon V Baudouin
Journal:  Intensive Care Med       Date:  2010-03-12       Impact factor: 17.440

4.  Multi-system neurological disease is common in patients with OPA1 mutations.

Authors:  P Yu-Wai-Man; P G Griffiths; G S Gorman; C M Lourenco; A F Wright; M Auer-Grumbach; A Toscano; O Musumeci; M L Valentino; L Caporali; C Lamperti; C M Tallaksen; P Duffey; J Miller; R G Whittaker; M R Baker; M J Jackson; M P Clarke; B Dhillon; B Czermin; J D Stewart; G Hudson; P Reynier; D Bonneau; W Marques; G Lenaers; R McFarland; R W Taylor; D M Turnbull; M Votruba; M Zeviani; V Carelli; L A Bindoff; R Horvath; P Amati-Bonneau; P F Chinnery
Journal:  Brain       Date:  2010-02-15       Impact factor: 13.501

5.  Gimap3 regulates tissue-specific mitochondrial DNA segregation.

Authors:  Riikka Jokinen; Paula Marttinen; Helen Katarin Sandell; Tuula Manninen; Heli Teerenhovi; Timothy Wai; Daniella Teoli; J C Loredo-Osti; Eric A Shoubridge; Brendan J Battersby
Journal:  PLoS Genet       Date:  2010-10-14       Impact factor: 5.917

Review 6.  Transmission of mitochondrial DNA diseases and ways to prevent them.

Authors:  Joanna Poulton; Marcos R Chiaratti; Flávio V Meirelles; Stephen Kennedy; Dagan Wells; Ian J Holt
Journal:  PLoS Genet       Date:  2010-08-12       Impact factor: 5.917

7.  Mitochondrial DNA Heteroplasmy Associations With Neurosensory and Mobility Function in Elderly Adults.

Authors:  Gregory J Tranah; Kristine Yaffe; Shana M Katzman; Ernest T Lam; Ludmila Pawlikowska; Pui-Yan Kwok; Nicholas J Schork; Todd M Manini; Stephen Kritchevsky; Fridtjof Thomas; Anne B Newman; Tamara B Harris; Anne L Coleman; Michael B Gorin; Elizabeth P Helzner; Michael C Rowbotham; Warren S Browner; Steven R Cummings
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-08-31       Impact factor: 6.053

8.  Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS.

Authors:  Mahsa Mehrazin; Sara Shanske; Petra Kaufmann; Ying Wei; Jorida Coku; Kristin Engelstad; Ali Naini; Darryl C De Vivo; Salvatore DiMauro
Journal:  Am J Med Genet A       Date:  2009-02-15       Impact factor: 2.802

9.  Purifying Selection against Pathogenic Mitochondrial DNA in Human T Cells.

Authors:  Melissa A Walker; Caleb A Lareau; Leif S Ludwig; Amel Karaa; Vijay G Sankaran; Aviv Regev; Vamsi K Mootha
Journal:  N Engl J Med       Date:  2020-08-12       Impact factor: 91.245

Review 10.  The inheritance of pathogenic mitochondrial DNA mutations.

Authors:  L M Cree; D C Samuels; P F Chinnery
Journal:  Biochim Biophys Acta       Date:  2009-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.